US Patent 9216205 Modified polynucleotides encoding granulysin
Patent 9216205 was granted and assigned to Moderna Therapeutics on December, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+229 characters)
Article
Patent abstract
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of oncology-related polynucleotides, oncology-related primary transcripts and oncology-related mmRNA molecules.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09216205 Modified polynucleotides encoding granulysin US Patent 9216205 Modified polynucleotides encoding granulysin
Infobox
Patent Number
09216205
Patent Number
9216205
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09216205 Modified polynucleotides encoding granulysin
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09216205
Date of patent
December 22, 2015
Patent application number
14107053
Date Filed
December 16, 2013
Patent primary examiner
Find more entities like US Patent 9216205 Modified polynucleotides encoding granulysin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.